Meta-analysis of everolimus-eluting versus paclitaxel-eluting stents in coronary artery disease: final 3-year results of the SPIRIT clinical trials program (Clinical Evaluation of the Xience V Everolimus Eluting Coronary Stent System in the Treatment of Patients With De Novo Native Coronary Artery Lesions). [electronic resource]
Producer: 20140519Description: 914-22 p. digitalISSN:- 1876-7605
- Aged
- Cardiovascular Agents -- administration & dosage
- Coronary Artery Disease -- diagnosis
- Coronary Restenosis -- etiology
- Coronary Thrombosis -- etiology
- Drug-Eluting Stents
- Everolimus
- Female
- Humans
- Kaplan-Meier Estimate
- Male
- Middle Aged
- Multicenter Studies as Topic
- Multivariate Analysis
- Myocardial Infarction -- etiology
- Paclitaxel -- administration & dosage
- Percutaneous Coronary Intervention -- adverse effects
- Proportional Hazards Models
- Prosthesis Design
- Randomized Controlled Trials as Topic
- Risk Factors
- Sirolimus -- administration & dosage
- Time Factors
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article; Meta-Analysis; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.